(Q36286401)

13 August 2017

1 reference

title

Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression (English)

1 reference

13 August 2017

1 reference

Joseph F Goldberg

1

1 reference

13 August 2017

S Nassir Ghaemi

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

7 Suppl 5

1 reference

13 August 2017

page(s)

3-12

1 reference

The long-term natural history of the weekly symptomatic status of bipolar I disorder

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

The long-term course of rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Antidepressant properties of anticonvulsant drugs for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Can antidepressants cause mania and worsen the course of affective illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Antidepressant treatment in bipolar versus unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

One-year outcome with antidepressant--treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Antidepressant monotherapy for bipolar type II major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Divalproex in the treatment of bipolar depression: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

'Bipolarity' in bipolar disorder: distribution of manic and depressive symptoms in a treated population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Maintenance efficacy of divalproex in the prevention of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Antisuicide properties of psychotropic drugs: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00251.X

10.1111/J.1399-5618.2005.00251.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference